Literature DB >> 6483571

Effects of methoxy groups in the NI-substituent of sulfonamides on the pathways of elimination in man. The acetylation-deacetylation equilibrium and mechanisms of renal excretion of sulfisomidine, sulfamethomidine and sulfadimethoxine.

T B Vree, Y A Hekster, M W Tijhuis, M Baakman, M J Oosterbaan, E F Termond.   

Abstract

Sulfisomidine, sulfamethomidine, sulfadimethoxine and their corresponding N4-acetyl derivatives were administered to man. The percentages of acetylation and deacetylation and those of protein binding, the half-lives of elimination and the apparent and true renal clearance values were measured. No acetylation phenotype could be demonstrated in these compounds. Methoxy substitution in the NI-pyrimidine group of sulfisomidine affects predominantly the renal clearance value and mechanism of the parent compound but has no influence on the renal clearance of the N4-acetyl derivatives. The renal clearance value of sulfisomidine is 232 +/- 33 ml/min, of sulfamethomidine 21.60 +/- 16.4 ml/min and of sulfadimethoxine 10.87 +/- 10.44 ml/min. The renal clearance values of the corresponding N4-acetylsulfonamide derivatives are 314 +/- 91 ml/min, 342 +/- 63 ml/min and 202 +/- 65 ml/min respectively. Tubular reabsorption, caused by methoxy substitution in the NI-pyrimidine ring, lowers the rate of elimination and increases the half-life. The half-life of sulfisomidine is 8.5 +/- 0.5 h, of sulfamethomidine 27.8 +/- 5.3 h and of sufadimethoxine 34.6 +/- 10.4 h.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6483571     DOI: 10.1007/bf01954042

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  19 in total

Review 1.  Relationships between molecular structure and excretion of drugs.

Authors:  P Nielsen; F Rasmussen
Journal:  Life Sci       Date:  1975-11-15       Impact factor: 5.037

2.  [ON PHARMACOKINETICS OF SULFONAMIDES UNDER PATHOLOGICAL CONDITIONS].

Authors:  H BUETTNER; F PORTWICH; E MANZKE; N STAUDT
Journal:  Klin Wochenschr       Date:  1964-01-15

3.  Absorption and excretion of sulfamethomidine, a "long-acting" sulfonamide.

Authors:  L Z COOPER; M A MADOFF; L WEINSTEIN
Journal:  Antibiot Chemother (Northfield)       Date:  1962-10

4.  Metabolism and binding of N-(2-methyl-6-methoxy-4-pyrimidinyl) sulfanilamide (sulfamethomidine) in man.

Authors:  F J DICARLO; S G MALAMENT; L J HAYNES; G E PHILLIPS
Journal:  Toxicol Appl Pharmacol       Date:  1963-01       Impact factor: 4.219

Review 5.  Clinical pharmacokinetics of sulphonamides and their N4-acetyl derivatives.

Authors:  C A Hekster; T B Vree
Journal:  Antibiot Chemother (1971)       Date:  1982

6.  Pharmacokinetics of N1-acetyl- and N4-acetylsulphamethoxazole in man.

Authors:  T B Vree; Y A Hekster; J E Damsma; E van der Kleijn; W J O'Reilly
Journal:  Clin Pharmacokinet       Date:  1979 Jul-Aug       Impact factor: 6.447

Review 7.  Sulfonamides, structure-activity relationship, and mode of action. Structural problems of the antibacterial action of 4-aminobenzoic acid (PABA) antagonists.

Authors:  J K Seydel
Journal:  J Pharm Sci       Date:  1968-09       Impact factor: 3.534

8.  Isolation and identification of 4-hydroxysulfamerazine and preliminary studies on its pharmacokinetics in dogs.

Authors:  T B Vree; M W Tijhuis; J F Nouws; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1984-04-27

9.  [Physicochemical and biological studies on sulfonamides. 1. Pharmacologically interesting physicochemical characteristics of 21 sulfonamides and 6 sulfonamide metabolites].

Authors:  J RIEDER
Journal:  Arzneimittelforschung       Date:  1963-02

10.  Pharmacokinetics and mechanism of renal excretion of short acting sulphonamides and N4-acetylsulphonamide derivatives in man. Structural requirements of sulphonamides for active tubular secretion.

Authors:  T B Vree; Y A Hekster; J E Damsma; M Tijhuis; W T Friesen
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

View more
  4 in total

1.  Two-stage penetration of a single oral dose of sulphadimethoxine into skin blister fluid.

Authors:  A Nowak; A Klimowicz
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  The comparison of some pharmacokinetic parameters of sulphadimethoxine estimated by high performance liquid chromatography and three spectrophotometric methods.

Authors:  A Klimowicz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1989 Jul-Sep       Impact factor: 2.441

3.  Pharmacokinetics, N1-glucuronidation and N4-acetylation of sulfadimethoxine in man.

Authors:  T B Vree; E W Beneken Kolmer; M Martea; R Bosch; Y A Hekster; M Shimoda
Journal:  Pharm Weekbl Sci       Date:  1990-04-27

4.  Pharmacokinetics, N1-glucuronidation and N4-acetylation of sulfamethomidine in humans.

Authors:  T B Vree; E W Beneken Kolmer; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1991-10-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.